EUVIMEDEUVIMED entdecken
Crossref

26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)

Patrick Yue, Lingling Gu, Weihong Li, Haiyan Li, Yue Dun, jie pan, Yida Tang, qunsheng ji

JACC · 2026-04 · 87 (13) · A267

DOI: 10.1016/j.jacc.2026.02.663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Patrick Yue und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yue, P., Gu, L., Li, W., Li, H., Dun, Y., pan, J., Tang, Y., & ji, Q. (2026). 26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A). JACC, 87(13), A267. https://doi.org/10.1016/j.jacc.2026.02.663

Vancouver

Yue P, Gu L, Li W, Li H, Dun Y, pan J, et al. 26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A). JACC. 2026;87(13):A267. doi:10.1016/j.jacc.2026.02.663

BibTeX
@article{Yue2026,
  author = {Yue, Patrick and Gu, Lingling and Li, Weihong and Li, Haiyan and Dun, Yue and pan, jie and Tang, Yida and ji, qunsheng},
  title = {26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A267},
  doi = {10.1016/j.jacc.2026.02.663}
}
Kostenlos starten →